MARKET

STTK

STTK

Shattuck Labs, Inc.
NASDAQ
5.45
+0.06
+1.11%
Opening 09:50 06/24 EDT
OPEN
5.39
PREV CLOSE
5.39
HIGH
5.50
LOW
5.36
VOLUME
12.29K
TURNOVER
--
52 WEEK HIGH
8.33
52 WEEK LOW
0.7120
MARKET CAP
520.52M
P/E (TTM)
-8.5665
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at STTK last week (0615-0619)?
Weekly Report · 2d ago
Weekly Report: what happened at STTK last week (0608-0612)?
Weekly Report · 06/15 09:50
Top Biotech Gainers: SNSE Awaits Data In 2H, STTK To Begin Crohn's Trial In Q3, ALMS On Watch
NASDAQ · 06/15 02:02
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 06/12 17:05
Rezolve AI, Bakkt, Seagate And Other Big Stocks Moving Higher On Friday
Benzinga · 06/12 14:09
Insider Power Play: Shattuck Labs Director Makes Bold Stock Move
TipRanks · 06/12 02:01
Shattuck Labs director Clay B. Siegall buys 62,500 common shares for $250,000
PUBT · 06/11 21:00
Shattuck Labs Prices Upsized Public Equity and Warrant Offering
TipRanks · 06/11 12:45
More
About STTK
Shattuck Labs, Inc. is a biotechnology company. The Company is engaged in the development of treatments for inflammatory and immune-mediated diseases. Its lead product candidate, SL-325, is a monoclonal antibody that is designed to bind to death receptor 3 (DR3) and inhibit its interaction with its ligand, TL1A. TL1A is a costimulatory ligand in the tumor necrosis factor superfamily, which activates immune responses through binding a single receptor, DR3. The Company is conducting a Phase I clinical trial in healthy volunteers. In addition, the Company is also developing SL-425, a half-life extended version of SL-325. It is also developing multiple preclinical DR3-based bispecific antibodies, which are designed to inhibit both the DR3/TL1A axis and another biologically relevant target for the treatment of patients with inflammatory bowel disease.

Webull offers Shattuck Labs Inc stock information, including NASDAQ: STTK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STTK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading STTK stock methods without spending real money on the virtual paper trading platform.